Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
As the novel coronavirus (COVID-19) pandemic persists in causing mortalities worldwide, even with the vaccine availability, the research is highlighting the impact of the virus. For instance, we now understand how COVID-19 attacks the body's systems. With discoveries still emerging, a considerable amount of data suggests that in addition to identifying risks for disease (i.e., comorbidities and respiratory conditions), COVID-19 survivors experience cardiac injuries even though they never had underlying heart problems [1-4]. Heart health experts notice that recovered COVID-19 patients suffer major prolonged complications and require ongoing support and treatment. Insufficient oxygen, myocarditis, myocardial infarction, and cardiomyopathy are a few constellations of conditions described with post-COVID-19 patients. With the use of cardiovascular magnetic resonance (CMR) imaging, one study reported cardiac injury in 78% of COVID-19 survivors, while 60% had ongoing myocardial inflammation [5]. Another study applying echocardiography measurements noted damage in left ventricular (LV) diastolic and right ventricular (RV) function [6]. The cardiac sequelae from COVID-19 experience with recovered individuals significantly compromise their cardiorespiratory system to function properly. Unfortunately, this can cause them to suffer long-term disabilities. In addition to cardiac damage, the persistence of symptoms known as COVID long haul after months of being free from the virus leaves a tremendous effect on the health of some recovered individuals, but not all. Headaches, breathing difficulties, muscle aches and pain, brain fog, chronic cough, loss of olfactory sensation and taste are just several ongoing symptoms with former COVID-19 patients [7]. With the high number of post-COVID-19 survivors experiencing cardiovascular damage and the long-lasting effects, should health services in partnership with other healthcare sectors support COVID-19 patients with their recovery? Without proper treatment in place, survivors' life expectancy could significantly decline compared to the general population. It is then appropriate because
European Heart Journal, 2022
Emerging as a new epidemic, long COVID or post-acute sequelae of coronavirus disease 2019 (COVID-19), a condition characterized by the persistence of COVID-19 symptoms beyond 3 months, is anticipated to substantially alter the lives of millions of people globally. Cardiopulmonary symptoms including chest pain, shortness of breath, fatigue, and autonomic manifestations such as postural orthostatic tachycardia are common and associated with significant disability, heightened anxiety, and public awareness. A range of cardiovascular (CV) abnormalities has been reported among patients beyond the acute phase and include myocardial inflammation, myocardial infarction, right ventricular dysfunction, and arrhythmias. Pathophysiological mechanisms for delayed complications are still poorly understood, with a dissociation seen between ongoing symptoms and objective measures of cardiopulmonary health. COVID-19 is anticipated to alter the long-term trajectory of many chronic cardiac diseases whi...
European Journal of Medical and Health Sciences
Cardiac rehabilitation is a much appreciated but underutilized treatment strategy for cardiovascular disease. Traditional center-based cardiac rehabilitation program has been suspended due to the concrete measures adopted to flatten the COVID-19 pandemic curve. The current situation of emphasis the need of alternative approach for cardiac rehabilitation. This review shed light on consequences of COVID-19 disease on cardiac rehabilitation, the alternative approaches of cardiac rehabilitation, its potential advantages, and limitations as well as future directions.
Clinical Research in Cardiology, 2021
Background COVID-19 has caused considerable morbidity and mortality worldwide and cardiac involvement has been reported during infection. The short-term cardiac outcome in survivors of COVID-19 is not known. Objective To examine the heart of patients who survived COVID-19 and to compare the cardiac outcome between patients who recovered from mild-to-moderate or severe illness. Methods With use of ECG and echocardiography, we examined the heart of 105 patients who had been hospitalized with COVID-19 and were consecutively recruited after hospital discharge while attending follow-up visits. Survivors of COVID-19 were compared with 105 matched controls. We also compared the cardiac outcome and lung ultrasound scan between COVID-19 patients who had mild-to-moderate or severe illness. Results Cardiac data were collected a median of 41 days from the first detection of COVID-19. Symptoms were present in a low percentage of patients. In comparison with matched controls, no considerable stru...
Turkish Journal of Physical Medicine and Rehabilitation
Since the beginning of the pandemic, many novel coronavirus disease 2019 (COVID-19) patients have experienced multisystem involvement or become critically ill and treated in intensive care units, and even died. Among these systemic effects, cardiac involvement may have very important consequences for the patient’s prognosis and later life. Patients with COVID-19 may develop cardiac complications such as heart failure, myocarditis, pericarditis, vasculitis, acute coronary syndrome, and cardiac arrhythmias or trigger an accompanying cardiac disease. The ratio of COVID-19 cardiac involvement ranges between 7 and 28% in hospitalized patients with worse outcomes, longer stay in the intensive care unit, and a higher risk of death. Furthermore, deconditioning due to immobility and muscle involvement can be seen in post-COVID-19 patients and significant physical, cognitive and psychosocial impairments may be observed in some cases. Considering that the definition of health is “a state of co...
South African Journal of Physiotherapy
Patient presentation: Two cases of COVID-19 were admitted to a private healthcare facility in Johannesburg. They presented with shortness of breath and decreased endurance. One had COVID-19 myocarditis and the other chronic post-COVID-19 organising pneumonia with pulmonary fibrosis. Management and outcome: Both patients were admitted to ICU, provided oxygen therapy and supportive care as well as physiotherapy management in hospital and after hospital discharge. Physiotherapy management included inspiratory muscle training therapy, and cardiovascular and resistance exercise therapy. Improvements in peak expiratory flow rate and six-minute walk distance were observed for both cases at 6-and 7-months follow-up, respectively. Conclusion: Our case report illustrates the value of ongoing physiotherapy management, utilising progressive exercise therapy prescription, to aid the return to optimal functioning for survivors of COVID-19 in the intermediate phase of their recovery.
Revista Argentina de Cardiologia
Background: COVID-19 infection has been associated with cardiovascular complications in 7-28% of hospitalized patients, with the diagnosis based on biomarkers elevation. Subclinical cardiac involvement in outpatients recovered from COVID-19 represents a growing concern, as well as mid- or long-term cardiovascular effects. Objective: The aim of the present study was to determine the usefulness of detecting cardiovascular involvement in outpatients recovered from COVID-19, and its association with symptoms and risk factors. Methods: Between September 2020 and March 2021, 668 patients >18 years were prospectively included. All the patients had to have COVID-19 confirmed diagnosis by a positive reverse transcription-polymerase chain reaction (RT-PCR) test in a respiratory tract sample COVID-19. They were evaluated with physical examination, electrocardiogram (ECG) and Doppler echocardiography. Patients with symptoms suggestive of risk or abnormal findings on ECG or echocardiogram und...
Middle East Journal of Rehabilitation and Health Studies
The novel coronavirus-2019 (COVID-19), which spread rapidly and became a global pandemic, can cause respiratory failure, possibly requiring hospital stay or intensive care unit treatment. While COVID-19 primarily affects the respiratory system, evidence has shown that it may also affect other body organs such as the heart. Survivors of COVID-19 may develop physical, respiratory, cardiac, and psychological impairments as well as reduced quality of life. Also, the long-term consequences of COVID-19 remain unclear. Hence, cardiopulmonary rehabilitation should be started as soon as possible to alleviate dyspnea, preserve function, minimize disability, reduce complications, relieve anxiety, and improve quality of life. In this study, we summarized the current cardiopulmonary rehabilitation guidelines and protocols for patients with COVID-19.
COVID
In the context of new therapeutic protocols and vaccines developed in the past 3 years, coronavirus 2019 (COVID-19) continues to exert an important impact on the healthcare systems worldwide. Age and a history of cardiovascular or respiratory diseases remain relevant in terms of prognosis for all COVID-19 patients, independent of the viral strain, by conveying a worse outcome and increased rates of in-hospital mortality. Previous studies reported heterogenous cardiovascular manifestations in COVID-19 patients from acute myocarditis or myopericarditis, acute coronary syndromes, stress cardiomyopathy, de novo arrhythmias to pulmonary embolism, or in some rare cases, endocarditis. In this review, we assessed the potential acute, in-hospital and long-term cardiac complications in patients diagnosed with COVID-19.
BMC Cardiovascular Disorders
Background Besides the lungs, coronavirus disease 2019 (COVID-19) can affect the cardiovascular, digestive, urinary, hepatic, and central nervous systems. Other than its short-term effects, COVID-19 may also cause long-term complications. In this study, we assessed long-term COVID-19 cardiovascular symptoms among patients in a cardiovascular clinic. Method A retrospective cohort was conducted between October 2020 to May 2021 on patients at an outpatient cardiovascular clinic in Shiraz, Iran. Patients with a history of COVID-19 at least one year before their referral were included. Baseline information was extracted from the clinic’s database. Data were collected regarding symptoms like dyspnea, chest pain, fatigue, and palpitations after a year of COVID-19. We also noted any major adverse cardiac events (MACE). Results Most common symptoms after a year of COVID-19 were exertional dyspnea (51.2%), dyspnea at rest (41.6%), fatigue (39%), and chest pain (27.1%). The symptoms were more ...
2020
The global spread of SARS-CoV-2 with its diverse signs and symptoms manifested in COVID-19 patients across different age groups and geographic locations perplexed the clinicians and public health experts. Emerging variants of SARS-CoV-2 through continuous mutation with a limited arsenal of treatment made the study of viral pathogenesis and factors associated with disease outcomes in a holistic approach inevitable, among which pre-existing cardiovascular complications were found to be significantly associated with adverse outcome of COVID-19. In addition, COVID-19 has already been reported to cause cardiac injury and different cardiovascular complications in patients irrespective of preexisting cardiovascular complications, which highlights the importance of recognizing the complications at the onset, although these arising complications might be an indirect effect of SARS-CoV-2 induced cytokine storm or hypoxia rather the virus itself. Also, the drugs used for the clinical managemen...